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There is a need for simple and physiological assays to characterize the immune status of allergic
individuals. Whole blood samples from 15 adult subjects (10 with positive clinical history to grass
pollen and 5 with negative clinical history) were obtained before the start (April 2010) and during the
middle of the grass pollen season (June 2010). The investigators were blinded to the allergic status of
the subjects. A skin prick test (SPT) to grass pollen was carried out at the end of the study. Cytokines
(IL-5, IL-13, IL-10 and IFNg) and activation of T-lymphocytes were determined after ex vivo culture of
whole blood cells. IL-5, IL-10 and IL-13 cytokines were signiﬁcantly elevated in allergic individuals
during the middle of the season (pr0.02) compared to the start. This assay can be a valuable tool in
clinical trials especially in pediatric population where limited quantities of blood are available to study
immune responses.
& 2011 Elsevier B.V. Open access under CC BY-NC-ND license. 1. Introduction
Allergies are now a global health problem and affect 1 in every
5 individuals in the developed nations [11,12,23]. Depending on the
site of exposure and the sensitizing allergen the symptoms can
manifest in different anatomical locations and lead to skin, food
or respiratory allergy (rhinitis and asthma). Allergic reactions are
mediated by an immune bias towards a Th-2 phenotype. This bias
in the immune system is brought about by an increase in Th-2
cytokines (Interleukin-4, -5, -13) levels in allergy prone individuals
[5,22]. However, it is not well understood how the levels of these
Th-2 cytokines ﬂuctuate during seasonal exposure to the allergen [1]
and correlate to allergic symptoms. Among the different forms of
allergies, respiratory allergies (allergic rhinitis and allergic asthma)
are the most common and account for considerable morbidity both
in children and in adults [7,11,13,14]. Allergic rhinitis affects the
upper airways and common symptoms associated with the disorder
include runny and blocked nose, sneezing and nasal itching. Most
subjects also present with ocular symptoms (allergic rhino-con-
junctivitis) [2,3,27].
Allergic rhinitis can be classiﬁed into seasonal and perennial.
This classiﬁcation depends on the causative environmental: þ41 21 785 8544.
Singh).
rasse 10, CH-3010 Bern 22,
Y-NC-ND license. allergen. Seasonal allergies (hay-fever) typically occur in the
spring and summer season and the main causative allergens are
pollen from grass and trees [2,6]. The majority of clinical trials
conducted in seasonal allergy are performed in artiﬁcial settings
(nasal provocation tests and aerosol chambers) because of the
limited duration of the pollen season to a few months in a year.
These studies have been designed to assess the efﬁcacy of anti-
allergy medications such as anti-histaminic drugs and corticos-
teroids. More often than not, a relief in symptomatic parameters
was not paralleled by a reduction in the levels of Th-2 cytokines
in these well designed clinical trials [8,15,21]. We have sought to
study the levels of different immunological parameters in a
‘‘ﬁeld’’ trial setting, i.e. within the pollen season (at the start
and middle of pollen season). Our hypothesis was that the levels
of Th-2 cytokines ﬂuctuate in grass pollen allergic individuals
with the severity of the grass pollen exposure during the course of
the season and that this could be visualized via the whole blood
assay. Based on the cytokine proﬁle we could then predict the
allergic status of the participating subjects.2. Patients and methods
2.1. Subjects and design of study
The protocol was submitted to and accepted by the Ethics
Commission of the Hospital of Lausanne, Switzerland (‘‘Commis-
sion Cantonale d’Ethique pour la Recherche´ sur l’Etre Humain’’,
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Fig. 1. Protocol for the clinical study with whole blood assay in grass pollen allergics. (A) 2 visits for blood drawing once subjects were included in the protocol. First visit
(V1) was scheduled at the start of the grass pollen season (April 2010) and second visit (V2) in the middle of the pollen season (June 2010). (B) The pollen count in the city
of Lausanne coincided with the 2 visits, i.e. in April little pollen exposure (outside season) and in June the middle of the pollen exposure (inside season) was observed.
SPT to a grass pollen mix was carried out at the end of the study (V3).
A. Singh et al. / Results in Immunology 1 (2011) 18–23 19Lausanne, Switzerland) under the reference 63/10. The study was
performed at the Metabolic Unit facility at Nestle´ Research Center
(Study no. 10.02.MET), Lausanne, Switzerland between March and
August 2010. Fifteen adult subjects aged 20–50 years who gave
informed consent were recruited based on their clinical history
(10 with positive clinical history and 5 with negative clinical
history) of having allergic symptoms to grass pollen in the season
(baseline visit, V0). Exclusion criteria included subjects with a
history of anemia, regularly taking anti-allergy medications,
pregnancy, common cold (ﬂu-like) symptoms in the last month
and subjects currently participating or having participated in
another clinical trial. Two visits for 10 mL blood draws were
scheduled (Fig. 1A), ﬁrst visit at the start of the grass pollen
season (V1, April 2010) and second visit at the middle of the
season (V2, June 2010). The pollen counts in the city of Lausanne
coincided with the 2 visits, i.e. in April little pollen exposure, and
in June consistent pollen exposure were observed (Fig. 1B). A skin
prick test (SPT) to a mix of grass pollen (SOLUPRICK SQ, 6-grass
mix, ALK-Albello AG, Horsholm, Denmark) was conducted at the
end of the clinical study (V3, July–August 2010). Saline and
histamine were used as negative and positive controls, respec-
tively. Wheal and ﬂare responses were observed for 15 min and a
ﬁnal recording was done. Individuals with a mean wheal dia-
meter 43 mm were considered positive to the grass pollen
allergen. For all the analysis of the results, we considered subjects
with a positive SPT as true allergic subjects and those with a
negative SPT as non-allergic subjects. Thirteen subjects who had a
positive SPT to grass pollen at the end of the study were included
in the ﬁnal analysis.
2.2. Whole blood assay
Heparinized, venous blood (10 mL) from male and female adults
(20–50 years old) with a positive clinical history to grass pollen or
no allergy (no clinical history) was collected both at the start and
middle of the pollen season. Whole blood cells were cultured for
120 h (5 days) in a 1:5 dilution (100 mL of whole bloodþ400 mL of
culture media) in triplicate wells with culture medium RPMI (Sigma)
complemented with 1% L-glutamine, 1% Penicillin/Streptomycin,1% of non-essential amino acids (Invitrogen, Lucerne, Switzerland),
and 0.1% Gentamycin (Sigma). The cultures were carried out in 48
wells plate (Milian, Meyrin, Switzerland) either with no stimulation
(medium alone) or in the presence of different stimuli, mainly
anti-CD2 at a concentration of 2 mg/mL of each clone (Sanquin,
Amsterdam, Netherlands; Clones: CLB-T11.1/1, CLB-T11.1/2) and
anti-CD28 at a concentration of 4 mg/mL (Sanquin, Amsterdam,
Netherlands; Clone: CLB-CD28/1). For allergen-speciﬁc stimulation,
a 6-grass pollen mix extract (ALK-Albello AG, Horsholm, Denmark)
was used where the lyophilized extract (450 000 SQ/vial) was re-
suspended in RPMI and used at 100 mg/mL ﬁnal concentration. Cell
supernatants were collected from the triplicate wells and stored at
20 1C until analysis. For cytokine kinetics in the whole blood
culture supernatants in both un-stimulated and stimulated culture
conditions, the cultures were carried out for 48, 72 and 96 h.2.3. Flow cytometry and cytokine analysis
The centrifuged whole blood cell pellets were collected after
the 5-day culture from the triplicate wells, subjected to lysis of red
blood cells (RBC’s) and stained ﬁrst with cell surface and then with
intracellular ﬂuorochrome conjugated monoclonal antibodies (BD
Biosciences, San Jose, CA, USA) according to the manufacturer’s
protocol. The samples were analyzed via a 4 color FACS Calibur
ﬂow cytometer (BD, San Jose, CA, USA) for immune markers (CD3,
CD4 and CD25). Cytokines in the supernatant (IL-5, IL-10, IFNg and
IL-13) were measured by a human MESOSCALE kit (MesoScale
Discoverys, Gaithersburg, MD, USA).2.4. Statistical analyses
Data is expressed as arithmetic mean7standard error of the
mean (SEM). Paired t-test values of different cytokine levels at the
two visits were compared with Wilcoxon signed rank test for paired
observations, and the Mann–Whitney test, respectively, using the
GraphPad Prism 5 software (La Jolla, CA, USA). A difference of po0.05
was considered to be statistically signiﬁcant.
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3.1. Comparison of whole blood assay with SPT
Level of allergy related Th-2 cytokines (IL-5 and IL-13) were
measured in ex vivo stimulated whole blood cells both before the
start (V1, April 2010) and during the middle of the pollen season
(V2, June 2010). By comparing the level of Th-2 cytokines in the
whole blood assay of the 15 subjects, we identiﬁed 11 subjects in
the study as allergic subjects (subjects with 430% increase in
IL-5 and IL-13 level at V2 when compared to V1 visit). SPT to a
grass pollen mix was carried out at the end of this single blinded
study (V3, July 2010), which revealed 13 subjects to be sensitized
to grass pollen. When compared to SPT, the whole blood assay had
positive predictive value (PPV)¼100% (Table 1). This means that
subjects which had high level of the Th-2 cytokines (n¼11) also
tested positive for SPT to grass pollen. However, the whole blood
assay had a negative predictive value (NPV) of 50%, which indicates
that out of the subjects identiﬁed as negative by the whole blood
assay (n¼4), 2 subjects still tested as sensitized to grass pollen.
3.2. Kinetics of Th-2 cytokines IL-5 and IL-13 in ex vivo stimulated
whole blood cells from allergic subjects
To obtain the best conditions for stimulation in the whole
blood assay for our clinical study, we performed before the start
of the clinical study a kinetic response of allergy related cytokinesTable 1
SPTþ SPT Total
Whole bloodþ 11 (TP) 0 (FP) 11
Whole blood 2 (FN) 2 (TN) 4
Total 13 2 15
PPV¼100%.
NPV¼50%.
Subjects with high levels of IL-5 and IL-13 cytokines in the whole blood assay
(subjects with 430% increase in IL-5 and IL-13 levels at V2 when compared to V1
visit) were considered as whole blood positive (þ) and those with no increase
between the visits as whole blood negative (). Subjects with wheal diameter
43 mm on SPT with a grass pollen mix were considered SPTþ and those with no
wheal response or wheal diameter o3 mm were taken as SPT .
Positive predictive value (PPV) was calculated by the formula True Positive (TP)/
True Positive (TP)þFalse Positive (FP).
Negative predictive value (NPV) was calculated by the formula True Negative
(TN)/True Negative (TN)þFalse Negative (FN).
Fig. 2. Kinetics of Th-2 cytokines IL-5 and IL-13 in ex vivowhole blood assay. To optimiz
cytokines IL-5 (A) and IL-13 (B) were compared in whole blood cells from 2 grass pollen
points (48, 72, 96 h). Under stimulated conditions, the levels of the cytokines peake
un-stimulated conditions were detected.(IL-5 and IL-13) in the whole blood assay for different time points,
i.e. 48, 72, 96 h. Compared to un-stimulated conditions, IL-5 levels
started peaking in stimulated conditions after 72 h of culture of whole
blood cells (Fig. 2A). For IL-13 levels, 96 h of culture of whole blood
cells in stimulated conditions was necessary to differentiate from un-
stimulated conditions (Fig. 2B). For all donors in the study, we chose
to set whole blood assays for 120 h (5 days) in un-stimulated and
stimulated conditions to get a comprehensive view of their cytokine
response and also to be able to account for donor to donor variability.
3.3. Increased level of Th-2 cytokines, IL-5 and IL-13
in ex vivo stimulated whole blood cells between V1 and V2 visits
in allergic subjects
Whole blood cells obtained at V1 and V2 were stimulated ex vivo
with or without T-cell mitogens (anti-CD2þanti-CD28). The level of
Th-2 cytokines IL-5 and IL-13 were signiﬁcantly increased (p¼0.001)
in the supernatant of stimulated whole blood cells (Fig. 3A and B) at
V2 (middle of the grass pollen season, June 2010) when compared to
V1 (start of the grass pollen season, April 2010). No changes in un-
stimulated conditions were detected. There were also, no differences
in the level of the Th-1 cytokine IFNg (Fig. 3C) between the two visits.
Interestingly, levels of the immune-regulatory cytokine IL-10 (Fig. 3D)
were also increased (p¼0.03). These results suggest that with
continued exposure towards the peak of the pollen season there is
a shift in the immune system towards a Th-2 bias that can be
detected in ex vivo stimulated whole blood cells.
3.4. Whole blood assay as a tool to study allergen-speciﬁc ex vivo
immune responses
We stimulated whole blood cells collected at visit V2 with a
mixture of 6-grass pollen extracts ex vivo. Grass pollen stimula-
tion alone was not sufﬁcient to induce IL-5, IL-13 and IFNg levels,
but it stimulated IL-10 production. Stimulation with a combina-
tion of grass pollen and IL-2 led to secretion of IL-5, IL-13, IFNg
and IL-10 cytokines in the whole blood assay. However, IL-2 alone
was sufﬁcient to stimulate IL-5 and IL-13 while the induction of
IL-10 and IFNg was not modulated (Fig. 4A–D).4. Discussion
Previous studies have typically relied on measuring immune
responses in allergic individuals from isolated peripheral bloode culture conditions of whole blood cells before the start of the study, levels of Th-2
allergic donors between un-stimulated and stimulated conditions at different time
d in the whole blood assay typically at 96 h of culture, whereas no changes in
Fig. 3. Increased Th-2 cytokine level (IL-5 and IL-13) in ex vivo stimulated whole blood cells at V2 compared to V1 in allergic subjects. Levels of allergy related Th-2
cytokines (IL-5 and IL-13), Th-1 cytokine (IFNg) and the immune-regulatory cytokine (IL-10) were measured in ex vivo stimulated whole blood cells both before the start
(April 2010) and during the middle of the pollen season (June 2010). The levels of Th-2 cytokines IL-5 and IL-13 were signiﬁcantly increased (p¼0.001) in the supernatant
of stimulated whole blood cells during V2 (middle of grass pollen season) when compared to the V1 (start of the season). There were no differences in the levels of the Th-1
cytokine IFNg between the visits. Levels of the immune-regulatory cytokine IL-10 were also increased (p¼0.03).
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of Th-2 cytokines (IL-4, IL-5 and IL-13) following polyclonal and
allergen-speciﬁc stimulation of PBMCs ex vivo has been mea-
sured [10,16–18,29]. Isolating PBMCs and their subsequent
ex vivo culture is long and tedious and requires working with
large quantities of blood samples in order to obtain sufﬁcient
PBMCs to study immune responses. In the current study, we
have investigated the feasibility of setting up a fast and practical
assay that allows studying Th-2 speciﬁc immune responses in
allergic individuals in a ﬁeld setting via small amounts of
whole blood.
Fifteen subjects with (n¼10) or without (n¼5) a known
clinical history to grass pollen allergy were recruited. During
seasonal exposure it is well known that ﬂuctuations exist in
pollen counts in the environment (depending on other environ-
mental factors such as humidity and temperature) and the goal
was to schedule the two visits to coincide with baseline (V1,
before the start of the pollen season) and V2 (in the middle of the
season) for the study (Fig. 1A). An important point to consider for
the whole blood study is that it was single blinded in order to
enable the investigators to identify allergic subjects. Before the
start of the study, we identiﬁed optimal conditions for the whole
blood assay for analyzing Th-2 cytokines (Fig. 2). Comparing Th-2
cytokines under stimulated conditions between the visits V1
(start of the grass pollen season, April 2010) and V2 (middle ofthe grass pollen season, June 2010) we identiﬁed 11 out of the 15
subjects recruited as potential allergic subjects (subjects with
430% increase in IL-5 and IL-13 levels at V2 when compared to
V1 visit). These subjects were considered as whole blood positive.
When whole blood positive subjects were compared to SPT
positive subjects at the end of the study (V3, July 2010), the
whole blood assay had a positive predictive value (PPV)¼100%
(Table 1). This signiﬁes that subjects in the study who had high
levels of Th-2 cytokines (IL-5 and IL-13) at V2 compared to V1,
also tested positive for SPT to grass pollen (n¼11). Interestingly,
three out of the ﬁve subjects in our study who were recruited
with no previous clinical history to grass pollen were SPT positive
to grass pollen and 1 was whole blood positive. These ﬁndings are
intriguing and suggest that a substantial number of sensitized or
atopic subjects could be unaware of their allergic status and
remain undiagnosed in the general population. However, these
ﬁndings need to be further veriﬁed in a larger cohort of non-
allergic subjects.
While diagnostic tests such as SPT and measurement of
speciﬁc IgE levels (RAST, UniCAP) exist in the clinic today, these
tests only predict the levels of sensitization speciﬁc to the
allergen [21,23,24] and do not evaluate Th-2 cytokine level in
allergic subjects. We propose that an easy to implement assay
such as the whole blood assay that is both immunologically and
physiologically relevant could routinely be employed in a clinical
Fig. 4. Determination of allergen-speciﬁc responses via the whole blood assay. Whole blood cells were stimulated with a 6-grass pollen mix extract ex vivo (at V2, June
2010). Addition of IL-2 with or without the grass mix to the cultures is sufﬁcient to signiﬁcantly increase the secretion of Th-2 cytokines (p¼0.04). Detectable levels of IFNg
and IL-10 were obtained in the presence of both the allergen (grass mix) and IL-2 while IL-10 production could be induced with allergen stimulation alone.
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whole blood study was conducted in a ‘‘ﬁeld’’ trial like setting, i.e.
during the actual pollen season. We stimulated whole blood cells
ex vivo (with anti-CD2 and anti-CD28) rather than directly look at
serum levels of the Th-2 cytokines in order to get a comprehen-
sive view of the immune status of the subjects. This approach has
previously been described in allergy related trials focusing on
atopic eczema [19].
A signiﬁcant increase in the level of Th-2 cytokines (IL-5
and IL-13) in allergic subjects at V2 when compared to V1 visit
(Fig. 3A and B) was observed using the whole blood assay. While
the ﬁnding itself that Th-2 cytokines are elevated in the pollen
season when compared to out of the season is not new, the fact
that we could observe these changes (Fig. 1) simply by stimulat-
ing small quantities of whole blood provides validation to this
assay as a tool to study immune changes in allergics. We
evaluated two other cytokines, IFNg and IL-10 and compared
their level at both the visits (Fig. 3C and D). IFNg is a predomi-
nantly Th-1 cytokine and is known to shift the bias from Th-2
allergic responses. IL-10 is described as an immune-regulatory
cytokine that has the potential to inhibit Th-2 responses. Our
initial thinking was that there would be defects in secreting either
IFNg or IL-10 within the allergic population [4,22,24–26]. How-
ever, we did not observe any signiﬁcant changes in the levels of
IFNg during the two visits in allergic subjects. We also deter-
mined the percentages of activated T-cells in stimulated whole
blood cells of the subjects. No differences were evident in theactivation status of T-cell populations at both the visits (data not
shown).
Allergen-speciﬁc stimulation with a mix of grass pollen
extracts was also investigated, to examine cytokine levels during
both the visits (Fig. 4A–D). A combination of grass pollen and the
T-cell growth factor IL-2, stimulated production of IL-5, IL-13,
IL-10 and IFNg production. IL-2 alone was sufﬁcient to stimulate
IL-5 and IL-13 production. Grass stimulation alone did not increase
any cytokine other than IL-10. This possibly suggests that con-
tinued allergen exposure is necessary to maintain immune-reg-
ulatory (IL-10) responses but possibly not required to sustain
optimal allergen-speciﬁc Th-2 responses. However, compared to
the PBMC assay in which known cell numbers are cultured under
different conditions, the whole blood assay is meant to be a quick
and easy tool to get an immunological proﬁle to known stimuli.
In this assay there certainly are limitations such as the number of
cells plated per well, as this varies from donor to donor. We
continue to adapt this assay to better study allergen-speciﬁc
responses [9,20,28]. In summary, the whole blood cell assay is a
tool that can help to identify the allergic status of subjects in
parallel to SPT and measurement of speciﬁc IgE levels. The assay
allows studying of immune responses in grass pollen allergic
individuals at different time points of the allergic season. Future
studies are needed to study the effect of therapeutic interventions
on Th-2 cytokine levels in whole blood and evaluate cytokine
changes in whole blood in perennial (house dust mite) allergic
subjects.
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